Surveillance, Epidemiology, and End Results (SEER) Program
|
Resource Development
|
CDC
|
NCI
|
The Surveillance, Epidemiology, and End Results (SEER) program is the premier source for cancer statistics in the US. It collects information on incidence, prevalence, and survival from specific geographic areas representing 48 percent of the US population. Through SEER, NCI develops reports on all of these information areas plus cancer mortality for the entire country. The site is intended for anyone interested in US cancer statistics or cancer surveillance methods.
|
Synthetic DNA Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
OD/OSP
|
Re-examining and updating (if necessary) the Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA, which was released in 2010.
|
Systematic Evidence Review of Trauma Informed Care (TIC)
|
Research Initiative
|
AHRQ
|
NIMH
|
This project, a collaboration between the National Institute of Mental Health (NIMH) and the Agency for Healthcare Research and Quality (AHRQ) will aim to review the effectiveness of trauma-informed care in improving patient care and outcomes.
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, SAMHSA
|
NLM
|
SNOMED CT (formerly Systematized Nomenclature of Medicine Clinical Terms) is a comprehensive and precise, multilingual health terminology. It assists with the electronic exchange of clinical health information, can be mapped to other coding systems, and is a resource with extensive, scientifically validated clinical content. NLM serves as the US National Release Center (NRC) and member of SNOMED International and is responsible for creating and distributing the US Edition of SNOMED CT, as well as accepting content requests for inclusion in the US Edition of SNOMED CT. Collaborators such as VA, NCI, AHRQ, CDC, CMS, and FDA have integrated SNOMED CT into their resources and provided requests for content in the US Edition of SNOMED CT.
|
Systems Immunology of COVID-19
|
Research Initiative
|
FDA
|
NIAID
|
Systems Immunology of COVID-19
|
Systems immunology of influenza vaccination responses in healthy COVID-19 recovered individual versus those with no history of COVID-19
|
Research Initiative
|
FDA
|
NIAID
|
Systems immunology of influenza vaccination responses in healthy COVID-19 recovered individual versus those with no history of COVID-19
|
Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, ASPR
|
NIAID
|
Established by Executive Order 13676, the Task Force facilitates implementation of the CARB Action Plan and provides progress reports and quarterly updates describing key achievements. The Task Force is an internal government committee comprised of federal representatives and co-chaired by the Secretaries of Defense, Agriculture, and HHS.
|
Taxonomics Methods Using DNA
|
Research Initiative
|
FDA
|
NLM
|
Taxonomics Methods Using DNA
|
Technical Expert Panel on the development of Evidence-Based Practice Guide on the treatment of serious mental illness (SMI) in older adults.
|
Meeting/ Workshop
|
SAMHSA
|
NIMH
|
Substance Abuse and Mental Health Services Administration (SAMHSA) convened a technical expert panel to provide guidance on the development of an evidence-based practice guide on the treatment of serious mental illness in older adults. The guide is an important part of the 21st Century Cures Act's charge at SAMHSA to disseminate information on evidence-based practices and will address best practices for older adults.
|
The Administration for Strategic Preparedness and Response (ASPR)'s chemical, biological, radiological and nuclear defense subject matter expert team
|
Committee, Work group, Advisory group, or Task Force
|
OS, ASPR
|
NCI, NIAID
|
The National Cancer Institute (NCI) and the National Institute of Allergy and Infectious Diseases (NIAID) participate in Assistant Secretary for Preparedness and Response (ASPR)'s chemical, biological, radiological and nuclear defense team. Both NCI and NIAID provide expertise on radiation topics and for the Biomedical Advanced Research and Development Authority (BARDA), within the Office of ASPR in the U.S.
|